About
Small Molecule Drug Discovery
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
5
As Collaborator
1
Total Enrollment
291
By Phase
PHASE2: 3PHASE3: 1
By Status
RECRUITING: 2COMPLETED: 2ACTIVE_NOT_RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06482437Lead Sponsor
Safety and Efficacy of NMD670 in Adult Patients With Type 1 and Type 2 Charcot-Marie-Tooth Disease
PHASE2Active, not recruiting
80 participants
Started: Sep 30, 2024 · Completed: Dec 31, 2025
NCT06414954Lead Sponsor
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
PHASE2Recruiting
84 participants
Started: May 16, 2024 · Completed: Nov 1, 2025
NCT05794139Lead Sponsor
Safety and Efficacy of NMD670 in Ambulatory Adult Patients With Type 3 Spinal Muscular Atrophy
PHASE2Recruiting
54 participants
Started: Sep 21, 2023 · Completed: Jan 31, 2026
NCT05919407Collaborator
Pyridostigmine and Amifampridine for Myasthenia Gravis
PHASE3Unknown
24 participants
Started: Mar 22, 2023 · Completed: Sep 22, 2024
NCT04980807Lead Sponsor
Observational Study of Neuromuscular Function in CMT Type 1&2 and Healthy Controls
N/ACompleted
30 participants
Started: Apr 7, 2021 · Completed: Mar 3, 2022
Locations (1)
Headquarters
Aarhus, Denmark
Map
Loading map...